Enhanced production of reactive oxygen species in HeLa cells under concurrent low ‑dose carboplatin and Photofrin® photodynamic therapy.

In conclusion, the therapeutic enhancement of ccPDT in vitro was attributable to the carboplatin‑mediated synergetic production of OH▪ and apoptotic cellular damage, compared with Photofrin‑PDT alone. PMID: 29749554 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research